Synergistic effect of fatty liver and smoking on metabolic syndrome

Table 3 Prevalence of metabolic risk factors and metabolic syndrome among study subjects (n = 3455) classified by fatty liver and smoking habit n (%)

	Fatty liver (-)		Fatty liver (+)		P-value
	Non-smoker	Smoker	Non-smoker	Smoker
Central obesity1	497 (29.2)	51 (14.0)	501 (47.4)	137 (41.4)	< 0.0001
FPG ≥ 100 mg/dL	164 (9.6)	40 (11.0)	317 (30.0)	76 (23.0)	< 0.0001
High blood pressure2	356 (20.9)	63 (17.3)	477 (45.1)	119 (36.0)	< 0.0001
TG ≥ 150 mg/dL	207 (12.2)	103 (28.2)	478 (45.2)	197 (59.5)	< 0.0001
Low HDL-C3	223 (13.1)	71 (19.5)	320 (30.6)	147 (44.4)	< 0.0001
Metabolic syndrome	123 (7.2)	33 (9.0)	364 (34.4)	121 (36.6)	< 0.0001

¹Waist circumference in men ≥ 90 cm or in women ≥ 80 cm;

²Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg;

³High-density lipoprotein cholesterol in men < 40 mg/dL or in women < 50 mg/dL.